TRAIL/APO-2L与神经胶质瘤细胞凋亡
基金
"十五""2 11工程"重点学科建设项目 (教重办 2 0 0 2第 2号 )
河南省医学科技创新人才工程项目 (2 0 0 3112 0 0 7)
参考文献23
-
1Wiley S R, Schooiey K, Smolak P J, et al. Identification and characterization of a new member of the TNFfamily [ J ]. Immunity,1995,3:673 - 682.
-
2Ashkenazi A, Dixit V M. Death receptors: signaling and modulation [ J]. Science, 1998,281:1305 - 1308.
-
3Chinnaiyan AM, O Rourme K, YU GL, et al. Signal transduction by DR3, a death domain -containing receptor related to TNFRI and CD95 [J]. Science, 1996, 274:990-992.
-
4Pan G, Ni J, Wei YF, et al. An antagonist decoy receptor and a death domain -containing receptor for TRAIL [ J ]. Science,1997,277:815 - 818.
-
5Sheridan J P, Marsters S A,Pitti R M, et al. Control of TRAIL- induced apoptosis by a family of signaling and decoy receptors[J]. Science, 1997,277:818-821.
-
6Emery J G, Mcdonnell P, Burke M B,et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL [J]. J Biol chem,1998,273 : 14363 - 14367.
-
7Boldin M P, Varfolomeev E E, Pancer I, et al. A novel protein that interacts with the death domain of Fas/Apol contains a sequence motif related to the death domain [J]. JBiol chem, 1995,270:7795 -7798.
-
8Chinnaiyan A M, Teppert C G, Seldin M F, et al. FADD/MORT1 is a common mediator of CD95 and tumor necrosis factor receptor - induced apoptosis [ J ]. J Biol Chem, 1996,271:4961 - 4965.
-
9Sprick M R,Weigand M A, Rieser E, et al. FADD/MORT1 and caspase - 8 are recruited to TRAIL receptorsl and 2 and are essential for apoptosis mediated by TRAIL receptor2 [ J]. Immunity,2000,12, :599 - 609.
-
10CMM Van Geelen, EGE de Vries, TK Pie, et al. Differential modulation of the TRAIL receptoes and the CD95 receptor in colon carcinoma cell lines[ J]. British Journal of Cancer,2003,89:363 - 373.
二级参考文献7
-
1[1]Wiley SR,Schooley K,Smolak PJ et al.Identification and characterization of a new member of the TNF family that induces apoptosis.Immunity,1995,3:673
-
2[2]Pitti RM,Marsters SA,Ruppert S et al.Induction of apoptosis by Apo-2ligand, a new member of the tumor necrosis factor cytokine family.J Biol Chem,1996,271(22):12687
-
3[3]Griffith TS,Chin WA,Jackson GC et al. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol,1998,161:2833
-
4[4]Pan G,Ni J,Wei YF et al.An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science(Wash.DC),1997,277:815
-
5[5]Sheridan JP,Marsters SA,Pitti RM et al.Control ofTRAIL-induced apoptosis by a family of signaling and decoy receptors.Science(Wash.DC),1997,277:818
-
6[6]Frank S,Kohler U,Schackert G et al. Expression ofTRAIL and its receptors in human brain tumors.Biochem Biophys Res Commun,1999,257(2):454
-
7[7]Jo M,Kim TH,Seol DW,Esplen JE et al.Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related qpoptosis-inducing ligand.Nat Med,2000,6(5):564
共引文献10
-
1赵忠伟,高冬玲,王新军,刘泉,张云汉.颅咽管瘤中肿瘤坏死因子相关凋亡诱导配体受体的表达及意义[J].实用儿科临床杂志,2005,20(1):37-39. 被引量:2
-
2赵忠伟,高冬玲,陈奎生,王新军,张云汉.TRAIL受体在胶质母细胞瘤中的表达及意义[J].中国肿瘤临床,2005,32(7):375-377.
-
3赵忠伟,王新军,寿纪新,高冬玲,陈奎生,张云汉.间变性星形细胞瘤中肿瘤坏死因子相关凋亡诱导配体受体的表达及意义☆[J].中国神经精神疾病杂志,2005,31(3):165-167.
-
4赵忠伟,曹风雨,李晟磊,王新军,贺付成,张云汉.死亡受体在间变性星形细胞瘤中的表达研究[J].河南肿瘤学杂志,2005,18(4):229-230.
-
5赵忠伟,张云汉,王新军,单峤,寿纪新,高冬玲.间变性星形细胞瘤中DR4及DR5的表达[J].中国肿瘤临床与康复,2005,12(4):301-303.
-
6赵忠伟,陈奎生,王新军,李培栋,贺付成,张云汉.DR4及DR5在胶质母细胞瘤中的表达研究[J].河南大学学报(医学版),2006,25(1):10-12. 被引量:1
-
7李培栋,赵忠伟,王新军,高冬玲,张云汉.死亡受体4和5在颅咽管瘤中的表达[J].实用儿科临床杂志,2006,21(11):660-661. 被引量:1
-
8王晓云,李家栋,陈乾美,耿勇,赵厚育.标记TRAILR地高辛探针及原位杂交检测喉癌组织mRNA[J].贵阳医学院学报,2007,32(1):19-23. 被引量:1
-
9高冬玲,赵忠伟,张红新,张岚,陈奎生,张云汉.胶质母细胞瘤组织中TRAIL受体表达的研究[J].中国现代医学杂志,2007,17(19):2318-2321.
-
10张冠中 ,肖龙海 ,李新钢 .胶质瘤凋亡研究进展[J].河北医学,2004,10(2):184-186.
-
1吴惺,袁先厚,袁忠惠.TRAIL/APO-2L及其受体系统在脑肿瘤中的研究进展[J].国外医学(神经病学.神经外科学分册),2001,28(4):281-285.
-
2李卫国,李新钢,石梅,王东海,鲍修风.顺铂在TRAIL/APO-2L致胶质瘤细胞凋亡作用中影响机制的研究[J].中华神经外科杂志,2005,21(5):274-278. 被引量:4
-
3赵福军.前列腺癌自杀基因治疗研究进展[J].国外医学(泌尿系统分册),2002,22(5):295-297. 被引量:2
-
4郑晓勇.选择性杀癌细胞物:TRAIL/Apo-2L[J].国外医学(分子生物学分册),1999,21(1):43-45.
-
5黄俊琪,江丽芳,等.TRAIL及其受体系统、细胞凋亡与病毒感染[J].国外医学(病毒学分册),2002,9(5):137-141. 被引量:1
-
6刘少平,董卫国,罗和生,余琼芳,方春华,胡亚华,张险峰.结直肠癌患者血清血管生成素-2含量检测的临床意义[J].中华消化杂志,2009,29(2):128-129. 被引量:6
-
7张波,吴小翎.胃癌发生的基因改变及基因途径[J].胃肠病学和肝病学杂志,2003,12(6):595-597. 被引量:1
-
8葛艳丽,张俊杰,王志荣,黄滨滨.胃癌组织中血管内皮生长因子C的表达及其临床意义[J].实用癌症杂志,2015,30(2):159-161. 被引量:7
-
9刘艳波,蔡莲莲.IL-6与宫颈癌[J].国外医学(计划生育分册),2004,23(3):164-168. 被引量:1
-
10魏晓超,蔺新力,王新娟.肿瘤坏死因子相关的凋亡诱导配体及其与肿瘤治疗前景[J].生理科学进展,2001,32(1):18-22. 被引量:6